Radiosensitizing Pancreatic Cancer with PARP Inhibitor and Gemcitabine: An In Vivo and a Whole-Transcriptome Analysis after Proton or Photon Irradiation

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma is a devastating disease. Using modern technique of radiotherapy, such as proton therapy, may simultaneously enhance dose to the tumor and decrease dose to surrounding organ, thus limiting toxicity. Moreover, associating drugs to radiotherapy also inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Waissi, Waisse, Nicol, Anaïs, Jung, Matthieu, Rousseau, Marc, Jarnet, Delphine, Noel, Georges, Burckel, Hélène
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866541/
https://www.ncbi.nlm.nih.gov/pubmed/33573176
http://dx.doi.org/10.3390/cancers13030527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866541/
https://www.ncbi.nlm.nih.gov/pubmed/33573176
http://dx.doi.org/10.3390/cancers13030527

Ejemplares similares